NEW YORK--(BUSINESS WIRE)--Tyme Technologies, Inc. (OTC QB: TYMI), a research and development company focused on developing drug candidates for the treatment of cancer, today reported financial results for the quarter ended June 30, 2015.
“We are pleased with the progress made in the first half of this year,” said Steve Hoffman, Chief Executive Officer of the Company. “Following the completion of our reverse merger in March, we strengthened our team with a new CFO and expanded our medical advisory board.
Help employers find you! Check out all the jobs and post your resume.
